In the present report, our cellular study in human ccRCC cell lines also demonstrated that when METTL3 was depleted, the cell viability, migration ability, invasion ability, and tumor formation in vivo, were significantly inhibited. This evidence concerns the gene METTL3 and nonpapillary renal cell carcinoma.